These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 35694189)

  • 1. Characterizing the
    Li M; Keshavarz-Rahaghi F; Ladua G; Swanson L; Speers C; Renouf DJ; Lim HJ; Davies JM; Gill S; Stuart HC; Yip S; Loree JM
    Ther Adv Med Oncol; 2022; 14():17588359221097940. PubMed ID: 35694189
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Prognostic Impact of KRAS G12C Mutation in Patients with Metastatic Colorectal Cancer: A Multicenter Retrospective Observational Study.
    Chida K; Kotani D; Masuishi T; Kawakami T; Kawamoto Y; Kato K; Fushiki K; Sawada K; Kumanishi R; Shirasu H; Matsubara Y; Yuki S; Komatsu Y; Yamazaki K; Yoshino T
    Oncologist; 2021 Oct; 26(10):845-853. PubMed ID: 34232546
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Real-World Study of Characteristics and Treatment Outcomes Among Patients with KRAS p.G12C-Mutated or Other KRAS Mutated Metastatic Colorectal Cancer.
    Fakih M; Tu H; Hsu H; Aggarwal S; Chan E; Rehn M; Chia V; Kopetz S
    Oncologist; 2022 Aug; 27(8):663-674. PubMed ID: 35472176
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comprehensive Clinical and Molecular Characterization of
    Henry JT; Coker O; Chowdhury S; Shen JP; Morris VK; Dasari A; Raghav K; Nusrat M; Kee B; Parseghian C; Pant S; Jeyakumar N; Zhu L; Nishioka Y; Fogelman D; Wolff RA; Hong D; Overman MJ; Vauthey J; Kopetz S; Johnson B
    JCO Precis Oncol; 2021; 5():. PubMed ID: 34250391
    [TBL] [Abstract][Full Text] [Related]  

  • 5.
    Osterlund E; Ristimäki A; Kytölä S; Kuopio T; Heervä E; Muhonen T; Halonen P; Kallio R; Soveri LM; Sundström J; Keinänen M; Ålgars A; Ristamäki R; Sorbye H; Pfeiffer P; Nunes L; Salminen T; Lamminmäki A; Mäkinen MJ; Sjöblom T; Isoniemi H; Glimelius B; Osterlund P
    Front Oncol; 2022; 12():826073. PubMed ID: 35251991
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Retrospective Comparative Analysis of KRAS G12C
    Giampieri R; Lupi A; Ziranu P; Bittoni A; Pretta A; Pecci F; Persano M; Giglio E; Copparoni C; Crocetti S; Mandolesi A; Faa G; Coni P; Scartozzi M; Berardi R
    Front Oncol; 2021; 11():736104. PubMed ID: 34660299
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Study of Ras Mutations' Prognostic Value in Metastatic Colorectal Cancer: STORIA Analysis.
    Ottaiano A; Normanno N; Facchini S; Cassata A; Nappi A; Romano C; Silvestro L; De Stefano A; Rachiglio AM; Roma C; Maiello MR; Scala S; Delrio P; Tatangelo F; Di Mauro A; Botti G; Avallone A; Nasti G
    Cancers (Basel); 2020 Jul; 12(7):. PubMed ID: 32708575
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reclassification of
    Zhang X; Ma H; He Y; He W; Chen N; Li Y; Zhong W; Wu G; Zhou X; Hua H; Ye F; Cai H; Jiang W
    Ther Adv Med Oncol; 2024; 16():17588359231225035. PubMed ID: 38293276
    [TBL] [Abstract][Full Text] [Related]  

  • 9. KRAS G12C Metastatic Colorectal Cancer: Specific Features of a New Emerging Target Population.
    Schirripa M; Nappo F; Cremolini C; Salvatore L; Rossini D; Bensi M; Businello G; Pietrantonio F; Randon G; Fucà G; Boccaccino A; Bergamo F; Lonardi S; Dei Tos AP; Fassan M; Loupakis F
    Clin Colorectal Cancer; 2020 Sep; 19(3):219-225. PubMed ID: 32605718
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment Outcomes and Clinical Characteristics of Patients with KRAS-G12C-Mutant Non-Small Cell Lung Cancer.
    Arbour KC; Rizvi H; Plodkowski AJ; Hellmann MD; Knezevic A; Heller G; Yu HA; Ladanyi M; Kris MG; Arcila ME; Rudin CM; Lito P; Riely GJ
    Clin Cancer Res; 2021 Apr; 27(8):2209-2215. PubMed ID: 33558425
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular profile of KRAS G12C-mutant colorectal and non-small-cell lung cancer.
    Araujo LH; Souza BM; Leite LR; Parma SAF; Lopes NP; Malta FSV; Freire MCM
    BMC Cancer; 2021 Feb; 21(1):193. PubMed ID: 33632153
    [TBL] [Abstract][Full Text] [Related]  

  • 12. KRAS amplification in metastatic colon cancer is associated with a history of inflammatory bowel disease and may confer resistance to anti-EGFR therapy.
    Favazza LA; Parseghian CM; Kaya C; Nikiforova MN; Roy S; Wald AI; Landau MS; Proksell SS; Dueker JM; Johnston ER; Brand RE; Bahary N; Gorantla VC; Rhee JC; Pingpank JF; Choudry HA; Lee K; Paniccia A; Ongchin MC; Zureikat AH; Bartlett DL; Singhi AD
    Mod Pathol; 2020 Sep; 33(9):1832-1843. PubMed ID: 32376853
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    Jones GD; Caso R; Tan KS; Mastrogiacomo B; Sanchez-Vega F; Liu Y; Connolly JG; Murciano-Goroff YR; Bott MJ; Adusumilli PS; Molena D; Rocco G; Rusch VW; Sihag S; Misale S; Yaeger R; Drilon A; Arbour KC; Riely GJ; Rosen N; Lito P; Zhang H; Lyden DC; Rudin CM; Jones DR; Li BT; Isbell JM
    Clin Cancer Res; 2021 May; 27(9):2604-2612. PubMed ID: 33593884
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Prevalence and Concurrent Pathogenic Mutations of
    Liu Y; Li H; Zhu J; Zhang Y; Liu X; Li R; Zhang Q; Cheng Y
    Cancer Manag Res; 2021; 13():2447-2454. PubMed ID: 33758543
    [TBL] [Abstract][Full Text] [Related]  

  • 15. KRAS G12C mutation and risk of disease recurrence in stage I surgically resected lung adenocarcinoma.
    Gallina FT; Marinelli D; Melis E; Forcella D; Taje R; Buglioni S; Visca P; Torchia A; Cecere FL; Botticelli A; Santini D; Ciliberto G; Cappuzzo F; Facciolo F
    Lung Cancer; 2023 Jul; 181():107254. PubMed ID: 37253296
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic Outcomes and Clinical Features of Advanced Non-Small Cell Lung Cancer Carrying KRAS Mutations: A Multicenter Real-life Retrospective Study.
    Mazzaschi G; Perrone F; Minari R; Verzè M; Azzoni C; Bottarelli L; Pluchino M; Armillotta MP; Ubaldi A; Altimari A; Gruppioni E; Sperandi F; Andrini E; Guaitoli G; Bettelli S; Longo L; Bertolini F; Barbieri F; Pagano M; Bonelli C; Tagliavini E; Nicoli D; Ubiali A; Zangrandi A; Trubini S; Proietto M; Gnetti L; Tiseo M;
    Clin Lung Cancer; 2022 Nov; 23(7):e478-e488. PubMed ID: 36002369
    [TBL] [Abstract][Full Text] [Related]  

  • 17. KRAS G12C-mutated advanced non-small cell lung cancer: A real-world cohort from the German prospective, observational, nation-wide CRISP Registry (AIO-TRK-0315).
    Sebastian M; Eberhardt WEE; Hoffknecht P; Metzenmacher M; Wehler T; Kokowski K; Alt J; Schütte W; Büttner R; Heukamp LC; Stenzinger A; Jänicke M; Fleitz A; Zacharias S; Dille S; Hipper A; Sandberg M; Weichert W; Groschek M; von der Heyde E; Rauh J; Dechow T; Thomas M; Griesinger F;
    Lung Cancer; 2021 Apr; 154():51-61. PubMed ID: 33611226
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Large-scale clinico-genomic profile of non-small cell lung cancer with KRAS G12C: Results from LC-SCRUM-Asia study.
    Tamiya Y; Matsumoto S; Zenke Y; Yoh K; Ikeda T; Shibata Y; Kato T; Nishino K; Nakamura A; Furuya N; Miyamoto S; Kuyama S; Nomura S; Ikeno T; Udagawa H; Sugiyama E; Nosaki K; Izumi H; Sakai T; Hashimoto N; Goto K
    Lung Cancer; 2023 Feb; 176():103-111. PubMed ID: 36634571
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The dominant role of G12C over other KRAS mutation types in the negative prediction of efficacy of epidermal growth factor receptor tyrosine kinase inhibitors in non-small cell lung cancer.
    Fiala O; Pesek M; Finek J; Benesova L; Belsanova B; Minarik M
    Cancer Genet; 2013; 206(1-2):26-31. PubMed ID: 23313110
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutations matter: An observational study of the prognostic and predictive value of KRAS mutations in metastatic colorectal cancer.
    Lavacchi D; Fancelli S; Roviello G; Castiglione F; Caliman E; Rossi G; Venturini J; Pellegrini E; Brugia M; Vannini A; Bartoli C; Cianchi F; Pillozzi S; Antonuzzo L
    Front Oncol; 2022; 12():1055019. PubMed ID: 36523988
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.